NCCN Practice Guidelines for Breast Cancer.

R. W. Carlson, B. O. Anderson, W. Bensinger, C. E. Cox, N. E. Davidson, S. B. Edge, W. B. Farrar, L. J. Goldstein, W. J. Gradishar, A. S. Lichter, B. McCormick, L. M. Nabell, Elizabeth Cecile Reed, S. M. Silver, M. L. Smith, G. Somlo, R. Theriault, J. H. Ward, E. P. Winer, A. Wolff

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and ultimately select the most appropriate option from among the available alternatives. With rare exception, the evaluation, treatment, and follow-up recommendations contained within these guidelines were based largely on the results of past and present clinical trials. However, there is not a single clinical situation in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient and physician participation in prospective clinical trials allows patients not only to receive state-of-the-art cancer treatment but also to contribute to the improvement of treatment of future patients.

Original languageEnglish (US)
Pages (from-to)33-49
Number of pages17
JournalOncology (Williston Park, N.Y.)
Volume14
Issue number11 A
StatePublished - Jan 1 2000

Fingerprint

Practice Guidelines
Breast Neoplasms
Clinical Trials
Physicians
Therapeutics
Patient Participation
Guidelines
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Carlson, R. W., Anderson, B. O., Bensinger, W., Cox, C. E., Davidson, N. E., Edge, S. B., ... Wolff, A. (2000). NCCN Practice Guidelines for Breast Cancer. Oncology (Williston Park, N.Y.), 14(11 A), 33-49.

NCCN Practice Guidelines for Breast Cancer. / Carlson, R. W.; Anderson, B. O.; Bensinger, W.; Cox, C. E.; Davidson, N. E.; Edge, S. B.; Farrar, W. B.; Goldstein, L. J.; Gradishar, W. J.; Lichter, A. S.; McCormick, B.; Nabell, L. M.; Reed, Elizabeth Cecile; Silver, S. M.; Smith, M. L.; Somlo, G.; Theriault, R.; Ward, J. H.; Winer, E. P.; Wolff, A.

In: Oncology (Williston Park, N.Y.), Vol. 14, No. 11 A, 01.01.2000, p. 33-49.

Research output: Contribution to journalArticle

Carlson, RW, Anderson, BO, Bensinger, W, Cox, CE, Davidson, NE, Edge, SB, Farrar, WB, Goldstein, LJ, Gradishar, WJ, Lichter, AS, McCormick, B, Nabell, LM, Reed, EC, Silver, SM, Smith, ML, Somlo, G, Theriault, R, Ward, JH, Winer, EP & Wolff, A 2000, 'NCCN Practice Guidelines for Breast Cancer.', Oncology (Williston Park, N.Y.), vol. 14, no. 11 A, pp. 33-49.
Carlson RW, Anderson BO, Bensinger W, Cox CE, Davidson NE, Edge SB et al. NCCN Practice Guidelines for Breast Cancer. Oncology (Williston Park, N.Y.). 2000 Jan 1;14(11 A):33-49.
Carlson, R. W. ; Anderson, B. O. ; Bensinger, W. ; Cox, C. E. ; Davidson, N. E. ; Edge, S. B. ; Farrar, W. B. ; Goldstein, L. J. ; Gradishar, W. J. ; Lichter, A. S. ; McCormick, B. ; Nabell, L. M. ; Reed, Elizabeth Cecile ; Silver, S. M. ; Smith, M. L. ; Somlo, G. ; Theriault, R. ; Ward, J. H. ; Winer, E. P. ; Wolff, A. / NCCN Practice Guidelines for Breast Cancer. In: Oncology (Williston Park, N.Y.). 2000 ; Vol. 14, No. 11 A. pp. 33-49.
@article{c6af23e2d6b94fe68e395fd6741e1423,
title = "NCCN Practice Guidelines for Breast Cancer.",
abstract = "The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and ultimately select the most appropriate option from among the available alternatives. With rare exception, the evaluation, treatment, and follow-up recommendations contained within these guidelines were based largely on the results of past and present clinical trials. However, there is not a single clinical situation in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient and physician participation in prospective clinical trials allows patients not only to receive state-of-the-art cancer treatment but also to contribute to the improvement of treatment of future patients.",
author = "Carlson, {R. W.} and Anderson, {B. O.} and W. Bensinger and Cox, {C. E.} and Davidson, {N. E.} and Edge, {S. B.} and Farrar, {W. B.} and Goldstein, {L. J.} and Gradishar, {W. J.} and Lichter, {A. S.} and B. McCormick and Nabell, {L. M.} and Reed, {Elizabeth Cecile} and Silver, {S. M.} and Smith, {M. L.} and G. Somlo and R. Theriault and Ward, {J. H.} and Winer, {E. P.} and A. Wolff",
year = "2000",
month = "1",
day = "1",
language = "English (US)",
volume = "14",
pages = "33--49",
journal = "Oncology",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "11 A",

}

TY - JOUR

T1 - NCCN Practice Guidelines for Breast Cancer.

AU - Carlson, R. W.

AU - Anderson, B. O.

AU - Bensinger, W.

AU - Cox, C. E.

AU - Davidson, N. E.

AU - Edge, S. B.

AU - Farrar, W. B.

AU - Goldstein, L. J.

AU - Gradishar, W. J.

AU - Lichter, A. S.

AU - McCormick, B.

AU - Nabell, L. M.

AU - Reed, Elizabeth Cecile

AU - Silver, S. M.

AU - Smith, M. L.

AU - Somlo, G.

AU - Theriault, R.

AU - Ward, J. H.

AU - Winer, E. P.

AU - Wolff, A.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and ultimately select the most appropriate option from among the available alternatives. With rare exception, the evaluation, treatment, and follow-up recommendations contained within these guidelines were based largely on the results of past and present clinical trials. However, there is not a single clinical situation in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient and physician participation in prospective clinical trials allows patients not only to receive state-of-the-art cancer treatment but also to contribute to the improvement of treatment of future patients.

AB - The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. In many situations, the patient and physician have the responsibility to jointly explore and ultimately select the most appropriate option from among the available alternatives. With rare exception, the evaluation, treatment, and follow-up recommendations contained within these guidelines were based largely on the results of past and present clinical trials. However, there is not a single clinical situation in which the treatment of breast cancer has been optimized with respect to either maximizing cure or minimizing toxicity and disfigurement. Therefore, patient and physician participation in prospective clinical trials allows patients not only to receive state-of-the-art cancer treatment but also to contribute to the improvement of treatment of future patients.

UR - http://www.scopus.com/inward/record.url?scp=0034326445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034326445&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 33

EP - 49

JO - Oncology

JF - Oncology

SN - 0890-9091

IS - 11 A

ER -